These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28299534)

  • 1. Interdependence of Dosage Form Microstructure and Performance.
    Axel Zeitler J; Rades T
    Pharm Res; 2017 May; 34(5):887-889. PubMed ID: 28299534
    [No Abstract]   [Full Text] [Related]  

  • 2. Carrageenan as an efficient drug release modifier for ethylcellulose-coated pharmaceutical dosage forms.
    Siepmann F; Muschert S; Zach S; Leclercq B; Carlin B; Siepmann J
    Biomacromolecules; 2007 Dec; 8(12):3984-91. PubMed ID: 18039003
    [No Abstract]   [Full Text] [Related]  

  • 3. Practical considerations in development of solid dosage forms that contain cyclodextrin.
    Miller LA; Carrier RL; Ahmed I
    J Pharm Sci; 2007 Jul; 96(7):1691-707. PubMed ID: 17243148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal absorption II. Formulation factors affecting drug bioavailability.
    Blanchard J
    Am J Pharm Sci Support Public Health; 1978; 150(5):132-51. PubMed ID: 364993
    [No Abstract]   [Full Text] [Related]  

  • 6. Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs.
    Simšič T; Planinšek O; Baumgartner A
    Acta Pharm; 2024 Jun; 74(2):177-199. PubMed ID: 38815202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral absorption enhancement: taking the next steps in therapeutic delivery.
    Brayden DJ; Maher S
    Ther Deliv; 2010 Jul; 1(1):5-9. PubMed ID: 22816114
    [No Abstract]   [Full Text] [Related]  

  • 8. Dry blending process scale-up for a very low dose drug candidate.
    Wu LS; Pang J; Chen JG; Hussain MA
    AAPS PharmSciTech; 2000 Aug; 1(3):E-TN2. PubMed ID: 14727902
    [No Abstract]   [Full Text] [Related]  

  • 9. A new paradigm for improving oral absorption of drugs in discovery: role of physicochemical properties, different excipients and the pharmaceutical scientist.
    Wilson AG; Nouraldeen A; Gopinathan S
    Future Med Chem; 2010 Jan; 2(1):1-5. PubMed ID: 21426039
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of excipients on transporter mediated absorption.
    Goole J; Lindley DJ; Roth W; Carl SM; Amighi K; Kauffmann JM; Knipp GT
    Int J Pharm; 2010 Jun; 393(1-2):17-31. PubMed ID: 20417699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable isotope-labeled excipients for drug product identification and counterfeit detection.
    Felton LA; Shah PP; Sharp Z; Atudorei V; Timmins GS
    Drug Dev Ind Pharm; 2011 Jan; 37(1):88-92. PubMed ID: 20560792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of microwave in processing of drug delivery systems.
    Wong TW
    Curr Drug Deliv; 2008 Apr; 5(2):77-84. PubMed ID: 18393808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2012 Jan; 101(1):342-53. PubMed ID: 21935949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of excipient interactions on drug bioavailability from solid dosage forms.
    Panakanti R; Narang AS
    Pharm Res; 2012 Oct; 29(10):2639-59. PubMed ID: 22610283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manufacturing classification system (MCS): enabling better understanding of oral solid dosage formulation design.
    Leane M
    Pharm Dev Technol; 2024 Jun; 29(5):393-394. PubMed ID: 38738506
    [No Abstract]   [Full Text] [Related]  

  • 19. Roll compaction/dry granulation: pharmaceutical applications.
    Kleinebudde P
    Eur J Pharm Biopharm; 2004 Sep; 58(2):317-26. PubMed ID: 15296958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate drug release from solid oral dosage forms.
    Schreiner T; Schaefer UF; Loth H
    J Pharm Sci; 2005 Jan; 94(1):120-33. PubMed ID: 15761936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.